1. "Myeloma"
Formats
  1. Meeting Abstract (543)
  2. Journal Article (358)
  3. Review (36)
  4. Research Letter (19)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (6)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (988)
  2. Department of Medicine (988)
  3. Hematologic Malignancies, Division of (988)
  4. Myeloma (988)
  5. Hematologic Malignancies Research (651)
  6. Survivorship Research (356)

More Groups

People
  1. Alexander Lesokhin (363)
  2. Carl Landgren (336)
  3. Hani Hassoun (329)
  4. Sham Mailankody (282)
  5. Malin Hultcrantz (260)
  6. Heather Landau (239)

More People

Years
  1. 2025 (13)
  2. 2024 (69)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (303)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (85)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (22)

More Publications

Publishers
  1. American Society of Hematology (324)
  2. Elsevier Inc. (159)
  3. American Society of Clinical Oncology (87)
  4. Nature Publishing Group (83)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (988)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk-adapted melphalan and stem cell transplant for systemic light chain amyloidosis: A single institution experience
    Meeting Abstract

    Landau, H.; Fein, D. E.; Hassoun, H.; Bello, C.; Chou, J. F.; Devlin, S.; Giralt, S.; Comenzo, R. L.
    Blood (2012)

    Fulltext@MSK | Save
  • Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
    Journal Article

    Hirschhorn-Cymerman, D.; Budhu, S.; Kitano, S.; Liu, C.; Zhao, F.; Zhong, H.; Lesokhin, A. M.; Avogadri Connors, F.; Yuan, J.; Li, Y.; more...
    Journal of Experimental Medicine (2012)

    Fulltext@MSK | Save
  • Unstable angina associated with cisplatin and carboplatin in a patient with advanced melanoma
    Journal Article

    Khan, S.; Chen, C. L.; Brady, M. S.; Parameswaran, R.; Moore, R.; Hassoun, H.; Carvajal, R. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Lenalidomide after stem-cell transplantation for multiple myeloma
    Journal Article

    McCarthy, P. L.; Owzar, K.; Hofmeister, C. C.; Hurd, D. D.; Hassoun, H.; Richardson, P. G.; Giralt, S.; Stadtmauer, E. A.; Weisdorf, D. J.; Vij, R.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save
  • Clonal plasma cell pathophysiology and clinical features of disease are linked to clonal plasma cell expression of cyclin D1 in systemic light-chain amyloidosis
    Journal Article

    Zhou, P.; Hoffman, J.; Landau, H.; Hassoun, H.; Iyer, L.; Comenzo, R. L.
    Clinical Lymphoma, Myeloma and Leukemia (2012)

    Fulltext@MSK | Save
  • Immunologic correlates of the abscopal effect in a patient with melanoma
    Journal Article

    Postow, M. A.; Callahan, M. K.; Barker, C. A.; Yamada, Y.; Yuan, J.; Kitano, S.; Mu, Z.; Rasalan, T.; Adamow, M.; Ritter, E.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save
  • Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment
    Journal Article

    Lesokhin, A. M.; Hohl, T. M.; Kitano, S.; Cortez, C.; Hirschhorn-Cymerman, D.; Avogadri, F.; Rizzuto, G. A.; Lazarus, J. J.; Pamer, E. G.; Houghton, A. N.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Outcomes following salvage autologous stem cell transplant (SCT) for multiple myeloma
    Meeting Abstract

    Rondon, C. S.; Hassoun, H.; Chimento, D.; Jia, X.; Giralt, S.; Landau, H. J.
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Maintained hematologic and organ responses following risk adapted stem cell transplant (SCT) in systemic light-chain amyloidosis (AL) using bortezomib and dexamethasone as consolidation therapy
    Meeting Abstract

    Landau, H. J.; Hassoun, H.; Rosenzweig, M. A.; Bello, C.; Hoover, E.; Riedel, E.; Comenzo, R. L.
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
    Journal Article

    Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save